Treating dementia by blood brain barrier opening to increase glymphatic clearance - From mechanisms to therapeutic applications

Bidragets beskrivning

Alzheimer's disease (AD) currently complicates the lives of 50 million people with deterioration of mental skills and personality. Today AD costs 1 trillion € annually and by 2030 the cost will double. In OPEN-consortium we have detected failures in a brain clearance mechanism that lead to AD. Based on our findings, we have further developed novel tools for detecting the failing brain clearance along with new ways to boost the brain clearance, such that the AD development might be slowed down or even prevented. In the continued plans are that we will further increase the efficiency of the treatment options and expand our research to see how efficient our tools are in detecting and monitoring AD pathology in humans. We aim to develop novel multi-level treatment strategy that incorporates a spectrum of options extending from easy to use non-invasive therapies into more invasive treatments for advanced diseases states that can be tailored to suite patient treatment at individual level.
Visa mer

Startår

2021

Slutår

2023

Beviljade finansiering



Lauri Eklund Orcid -palvelun logo
162 500 €

Rollen i Finlands Akademis konsortium

Partner

Övriga parter i konsortiet

Partner
Uleåborgs universitet (335723)
162 500 €
Leader
Uleåborgs universitet (335720)
162 500 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprogram

Övriga uppgifter

Finansieringsbeslutets nummer

335722

Vetenskapsområden

Biokemi, cell- och molekylärbiologi

Forskningsområden

Solu- ja molekyylibiologia

Identifierade teman

brain, neuroscience